Journal article
FOXO1 represses PPARa-Mediated induction of FGF21 gene expression
Biochemical and biophysical research communications, Vol.644, pp.122-129
02/12/2023
DOI: 10.1016/j.bbrc.2023.01.012
PMID: 36640666
Abstract
Fibroblast growth factor 21 (FGF21) has emerged as a metabolic regulator that exerts potent anti-diabetic and lipid-lowering effects in animal models of obesity and type 2 diabetes, showing a protective role in fatty liver disease and hepatocellular carcinoma progression. Hepatic expression of FGF21 is regulated by PPARa and is induced by fasting. Ablation of FoxO1 in liver has been shown to increase FGF21 expression in hyperglycemia. To better understand the role of FOXO1 in the regulation of FGF21 expression we have modified HepG2 human hepatoma cells to overexpress FoxO1 and PPARa. Here we show that FoxO1 represses PPARa-mediated FGF21 induction, and that the repression acts on the FGF21 gene promoter without affecting other PPARa target genes. Additionally, we demonstrate that FoxO1 physically interacts with PPARa and that FoxO1/3/4 depletion in skeletal muscle contributes to increased Fgf21 tissue levels. Taken together, these data indicate that FOXO1 is a PPARa-interacting protein that antagonizes PPARa activity on the FGF21 promoter. Because other PPARa target genes remained unaffected, these results suggest a highly specific mechanism implicated in FGF21 regulation. We conclude that FGF21 can be specifically modulated by FOXO1 in a PPARa-dependent manner. (c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Details
- Title: Subtitle
- FOXO1 represses PPARa-Mediated induction of FGF21 gene expression
- Creators
- Ana Luisa De Sousa-Coelho - Algarve Biomedical CenterMar Gacias - Universitat de BarcelonaBrian T. O'Neill - Fraternal Order of EaglesJoana Relat - Instituto de Salud Carlos IIIWolfgang Link - Instituto de Investigaciones Biomédicas Sols-MorrealeDiego Haro - Universitat de BarcelonaPedro F. Marrero - Instituto de Salud Carlos III
- Resource Type
- Journal article
- Publication Details
- Biochemical and biophysical research communications, Vol.644, pp.122-129
- DOI
- 10.1016/j.bbrc.2023.01.012
- PMID
- 36640666
- NLM abbreviation
- Biochem Biophys Res Commun
- ISSN
- 0006-291X
- eISSN
- 1090-2104
- Publisher
- Elsevier
- Number of pages
- 8
- Grant note
- 2005SGR857 / Ajut de Suport als Grups de Recerca de Catalunya RTI2018-094629-B-I00 / Spanish Ministry of Science, Innovation and Universities; Spanish Government BFU2004-01925; BFU2007-67322/BMC / Ministerio de Educacion y Ciencia; Spanish Government
- Language
- English
- Date published
- 02/12/2023
- Academic Unit
- Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984375353802771
Metrics
13 Record Views